Sign in

Maze Therapeutics, Inc.

Dec-25 Dec-24 Dec-23 Dec-22
Total revenue 0.00 0.17 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00
Gross profit 0.00 0.17 0.00 0.00
Total operating expenses + 0.14 0.11 0.10 0.11
Operating income -0.14 0.06 -0.10 -0.11
Non-operating income (net) 0.01 0.00 0.00 0.00
Income before tax -0.13 0.05 -0.10 -0.11
Income tax expense 0.00
Net income -0.13 0.05 -0.10 -0.11
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23
Total revenue 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.17 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.02 0.00 0.00 0.00 0.00 0.00 0.17 0.00 0.00 0.00
Total operating expenses + 0.05 0.04 0.03 0.04 0.04 0.03 0.03 0.03 0.03 0.02 0.03
Operating income -0.03 -0.04 -0.03 -0.04 -0.04 -0.03 -0.02 0.14 -0.03 -0.02 -0.03
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.02 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03 0.14 -0.03 -0.03 -0.02
Income tax expense 0.00 0.00 0.00
Net income -0.02 -0.03 -0.03 -0.03 -0.03 -0.03 -0.02 0.14 -0.03 -0.03 -0.02
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22
Total cash and short-term investments + 0.34 0.20 0.03 0.10
Accounts receivable, net 0.00
Other current assets 0.01 0.00 0.00 0.01
Total current assets 0.35 0.20 0.03 0.11
Total non-current assets + 0.05 0.04 0.04 0.04
Total assets 0.40 0.24 0.07 0.15
Total current liabilities + 0.02 0.02 0.02 0.02
Total non-current liabilities + 0.02 0.02 0.05 0.03
Total liabilities 0.04 0.04 0.06 0.05
Total stockholders' equity + 0.35 0.20 0.01 0.10
Common shares outstanding 43 44 44 44
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23
Total cash and short-term investments + 0.35 0.34 0.38 0.26 0.29 0.20 0.15 0.18 0.00 0.03 0.00
Accounts receivable, net 0.02 0.00 0.00
Other current assets 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Total current assets 0.38 0.35 0.39 0.27 0.30 0.20 0.15 0.18 0.03
Total non-current assets + 0.04 0.05 0.03 0.03 0.03 0.04 0.04 0.04 0.04
Total assets 0.42 0.40 0.42 0.30 0.33 0.24 0.19 0.22 0.07
Total current liabilities + 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02
Total non-current liabilities + 0.06 0.02 0.02 0.02 0.02 0.02 0.08 0.46 0.05
Total liabilities 0.08 0.04 0.04 0.04 0.04 0.04 0.09 0.48 0.06
Total stockholders' equity + 0.34 0.35 0.38 0.26 0.29 0.20 0.10 -0.26 0.01
Common shares outstanding 54 43 46 44 44 44 44 44 44 44 44
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22
Operating cash flow + -0.11 0.08 -0.09 -0.10
Cash flow from investing + -0.17 0.00 0.00 0.00
Cash flow from financing + 0.28 0.09 0.02 0.00
Change in cash -0.01 0.17 -0.07 -0.10
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23
Operating cash flow + -0.04 -0.03 -0.02 -0.03 -0.03 -0.02 -0.02 0.15 -0.02 -0.02 -0.02
Cash flow from investing + 0.01 -0.10 -0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.04 0.00 0.14 0.00 0.13 0.07 0.00 0.00 0.02 0.02 0.00
Change in cash 0.01 -0.13 0.05 -0.03 0.10 0.05 -0.03 0.15 0.00 0.00 -0.02
4 days ago

Maze Therapeutics, Inc. (MAZE) - Net Income From Continuing Operations

1Y 2Y 5Y Max
9 days ago

Maze Therapeutics, Inc. (MAZE) - Income Before Tax

1Y 2Y 5Y Max
9 days ago

Maze Therapeutics, Inc. (MAZE) - Depreciation And Amortization

1Y 2Y 5Y Max
9 days ago

Maze Therapeutics, Inc. (MAZE) - Interest Expense

1Y 2Y 5Y Max
9 days ago

Maze Therapeutics, Inc. (MAZE) - Interest Income

1Y 2Y 5Y Max
9 days ago

Maze Therapeutics, Inc. (MAZE) - Net Interest Income

1Y 2Y 5Y Max
9 days ago

Maze Therapeutics, Inc. (MAZE) - Operating Expenses

1Y 2Y 5Y Max
9 days ago

Maze Therapeutics, Inc. (MAZE) - Research And Development

1Y 2Y 5Y Max
9 days ago

Maze Therapeutics, Inc. (MAZE) - Selling General And Administrative

1Y 2Y 5Y Max
9 days ago

Maze Therapeutics, Inc. (MAZE) - Operating Income

1Y 2Y 5Y Max
9 days ago